EP2848617 - DIARYL[A, G]QUINOLIZIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 18.11.2022 Database last updated on 12.07.2024 | |
Former | The patent has been granted Status updated on 10.12.2021 | ||
Former | Grant of patent is intended Status updated on 28.07.2021 | ||
Former | Examination is in progress Status updated on 03.07.2021 | ||
Former | Grant of patent is intended Status updated on 09.06.2021 | ||
Former | Examination is in progress Status updated on 10.01.2017 | Most recent event Tooltip | 27.04.2024 | Lapse of the patent in a contracting state New state(s): MK | published on 29.05.2024 [2024/22] | Applicant(s) | For all designated states Shanghai Institute of Materia Medica, Chinese Academy of Sciences 555 Zuchongzhi Road Zhangjiang, Pudong Shanghai 201203 / CN | [2015/12] | Inventor(s) | 01 /
LIU, Hong 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 02 /
ZHEN, Xuechu 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 03 /
SUN, Haifeng 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 04 /
ZHU, Liyuan 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 05 /
QIAN, Wangke 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 06 /
YU, Leiping 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 07 /
LI, Zeng 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 08 /
ZHOU, Shengbin 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 09 /
CAI, Wenxian 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 10 /
JIANG, Hualiang 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | 11 /
CHEN, Kaixian 555 Zuchongzhi Road Zhangjiang Pudong Shanghai 201203 / CN | [2015/12] | Representative(s) | Kador & Partner Part mbB Corneliusstraße 15 80469 München / DE | [N/P] |
Former [2022/02] | Kador & Partner PartG mbB Corneliusstraße 15 80469 München / DE | ||
Former [2015/12] | Kador & Partner Corneliusstraße 15 80469 München / DE | Application number, filing date | 13787305.5 | 09.05.2013 | [2022/02] | WO2013CN00549 | Priority number, date | CN201210142903 | 09.05.2012 Original published format: CN201210142903 | [2015/12] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013166862 | Date: | 14.11.2013 | Language: | ZH | [2013/46] | Type: | A1 Application with search report | No.: | EP2848617 | Date: | 18.03.2015 | Language: | EN | [2015/12] | Type: | B1 Patent specification | No.: | EP2848617 | Date: | 12.01.2022 | Language: | EN | [2022/02] | Search report(s) | International search report - published on: | CN | 14.11.2013 | (Supplementary) European search report - dispatched on: | EP | 22.01.2015 | Classification | IPC: | C07D455/03, A61K31/4375, A61P25/00, A61P25/18 | [2015/12] | CPC: |
C07D471/14 (EP,US);
A61P25/00 (EP);
A61P25/06 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/24 (EP);
A61P25/30 (EP);
A61P25/36 (EP);
A61P43/00 (EP);
C07D455/03 (EP,US);
C07D491/147 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/12] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | DIARYL[A,G-]CHINOLIZIDINVERBINDUNG, HERSTELLUNGSVERFAHREN DAFÜR, PHARMAZEUTISCHE ZUSAMMENSETZUNG UND VERWENDUNGEN DAVON | [2015/12] | English: | DIARYL[A, G]QUINOLIZIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF | [2015/12] | French: | COMPOSÉ DIARYL[A, G]QUINOLIZIDINE, SON PROCÉDÉ DE PRÉPARATION, COMPOSITION PHARMACEUTIQUE, ET LEURS UTILISATIONS | [2015/12] | Entry into regional phase | 08.12.2014 | Translation filed | 08.12.2014 | National basic fee paid | 08.12.2014 | Search fee paid | 08.12.2014 | Designation fee(s) paid | 08.12.2014 | Examination fee paid | Examination procedure | 08.12.2014 | Examination requested [2015/12] | 05.08.2015 | Amendment by applicant (claims and/or description) | 10.12.2015 | Despatch of a communication from the examining division (Time limit: M06) | 04.05.2016 | Reply to a communication from the examining division | 08.09.2016 | Despatch of a communication from the examining division (Time limit: M04) | 09.01.2017 | Reply to a communication from the examining division | 18.05.2017 | Despatch of a communication from the examining division (Time limit: M06) | 27.11.2017 | Reply to a communication from the examining division | 11.07.2018 | Despatch of a communication from the examining division (Time limit: M04) | 08.11.2018 | Reply to a communication from the examining division | 27.01.2020 | Despatch of a communication from the examining division (Time limit: M04) | 20.05.2020 | Reply to a communication from the examining division | 30.07.2020 | Despatch of a communication from the examining division (Time limit: M04) | 09.12.2020 | Reply to a communication from the examining division | 09.06.2021 | Communication of intention to grant the patent | 01.07.2021 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 29.07.2021 | Communication of intention to grant the patent | 02.12.2021 | Fee for grant paid | 02.12.2021 | Fee for publishing/printing paid | 02.12.2021 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.12.2015 | Opposition(s) | 13.10.2022 | No opposition filed within time limit [2022/51] | Fees paid | Renewal fee | 27.05.2015 | Renewal fee patent year 03 | 31.03.2016 | Renewal fee patent year 04 | 24.05.2017 | Renewal fee patent year 05 | 22.05.2018 | Renewal fee patent year 06 | 23.05.2019 | Renewal fee patent year 07 | 29.05.2020 | Renewal fee patent year 08 | 21.05.2021 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 09.05.2013 | AL | 12.01.2022 | AT | 12.01.2022 | CY | 12.01.2022 | CZ | 12.01.2022 | DK | 12.01.2022 | EE | 12.01.2022 | FI | 12.01.2022 | HR | 12.01.2022 | LT | 12.01.2022 | LV | 12.01.2022 | MC | 12.01.2022 | MK | 12.01.2022 | PL | 12.01.2022 | RO | 12.01.2022 | RS | 12.01.2022 | SK | 12.01.2022 | SM | 12.01.2022 | BG | 12.04.2022 | NO | 12.04.2022 | GR | 13.04.2022 | IE | 09.05.2022 | LU | 09.05.2022 | IS | 12.05.2022 | PT | 12.05.2022 | [2024/22] |
Former [2024/20] | HU | 09.05.2013 | |
AL | 12.01.2022 | ||
AT | 12.01.2022 | ||
CY | 12.01.2022 | ||
CZ | 12.01.2022 | ||
DK | 12.01.2022 | ||
EE | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
MC | 12.01.2022 | ||
PL | 12.01.2022 | ||
RO | 12.01.2022 | ||
RS | 12.01.2022 | ||
SK | 12.01.2022 | ||
SM | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IE | 09.05.2022 | ||
LU | 09.05.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2024/18] | HU | 09.05.2013 | |
AL | 12.01.2022 | ||
AT | 12.01.2022 | ||
CZ | 12.01.2022 | ||
DK | 12.01.2022 | ||
EE | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
MC | 12.01.2022 | ||
PL | 12.01.2022 | ||
RO | 12.01.2022 | ||
RS | 12.01.2022 | ||
SK | 12.01.2022 | ||
SM | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IE | 09.05.2022 | ||
LU | 09.05.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2023/20] | AL | 12.01.2022 | |
AT | 12.01.2022 | ||
CZ | 12.01.2022 | ||
DK | 12.01.2022 | ||
EE | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
MC | 12.01.2022 | ||
PL | 12.01.2022 | ||
RO | 12.01.2022 | ||
RS | 12.01.2022 | ||
SK | 12.01.2022 | ||
SM | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IE | 09.05.2022 | ||
LU | 09.05.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2023/08] | AL | 12.01.2022 | |
AT | 12.01.2022 | ||
CZ | 12.01.2022 | ||
DK | 12.01.2022 | ||
EE | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
MC | 12.01.2022 | ||
PL | 12.01.2022 | ||
RO | 12.01.2022 | ||
RS | 12.01.2022 | ||
SK | 12.01.2022 | ||
SM | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
LU | 09.05.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2023/06] | AL | 12.01.2022 | |
AT | 12.01.2022 | ||
CZ | 12.01.2022 | ||
DK | 12.01.2022 | ||
EE | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
MC | 12.01.2022 | ||
PL | 12.01.2022 | ||
RO | 12.01.2022 | ||
RS | 12.01.2022 | ||
SK | 12.01.2022 | ||
SM | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2023/01] | AL | 12.01.2022 | |
AT | 12.01.2022 | ||
CZ | 12.01.2022 | ||
DK | 12.01.2022 | ||
EE | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
PL | 12.01.2022 | ||
RO | 12.01.2022 | ||
RS | 12.01.2022 | ||
SK | 12.01.2022 | ||
SM | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2022/49] | AT | 12.01.2022 | |
CZ | 12.01.2022 | ||
DK | 12.01.2022 | ||
EE | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
PL | 12.01.2022 | ||
RO | 12.01.2022 | ||
RS | 12.01.2022 | ||
SK | 12.01.2022 | ||
SM | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2022/48] | AT | 12.01.2022 | |
CZ | 12.01.2022 | ||
DK | 12.01.2022 | ||
EE | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
PL | 12.01.2022 | ||
RO | 12.01.2022 | ||
RS | 12.01.2022 | ||
SM | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2022/47] | AT | 12.01.2022 | |
DK | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
PL | 12.01.2022 | ||
RO | 12.01.2022 | ||
RS | 12.01.2022 | ||
SM | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2022/46] | AT | 12.01.2022 | |
DK | 12.01.2022 | ||
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
PL | 12.01.2022 | ||
RS | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2022/42] | AT | 12.01.2022 | |
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
PL | 12.01.2022 | ||
RS | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
IS | 12.05.2022 | ||
PT | 12.05.2022 | ||
Former [2022/39] | AT | 12.01.2022 | |
FI | 12.01.2022 | ||
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
PL | 12.01.2022 | ||
RS | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
PT | 12.05.2022 | ||
Former [2022/36] | AT | 12.01.2022 | |
HR | 12.01.2022 | ||
LT | 12.01.2022 | ||
LV | 12.01.2022 | ||
PL | 12.01.2022 | ||
RS | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
GR | 13.04.2022 | ||
PT | 12.05.2022 | ||
Former [2022/35] | HR | 12.01.2022 | |
LT | 12.01.2022 | ||
RS | 12.01.2022 | ||
BG | 12.04.2022 | ||
NO | 12.04.2022 | ||
PT | 12.05.2022 | ||
Former [2022/34] | LT | 12.01.2022 | |
NO | 12.04.2022 | ||
PT | 12.05.2022 | ||
Former [2022/33] | LT | 12.01.2022 | |
NO | 12.04.2022 | Documents cited: | Search | [X]JPS5024299 (NIPPON CHEMIPHAR CO) [X] 1-4,7 * the whole document *; | [X]WO2010075469 (CVI PHARMACEUTICALS LTD [GB], et al) [X] 1-4 * page 161 - page 174; examples 11, 19, 30, 33-34, 39, 62, 72, 74 *; | [X] - JB BREMNER ET AL, "Synthesis of Some Thieno Analogs of the Protoberberine and Protopine Skeletons. X-Ray Crystal Structure of 9,10-Dimethoxy-5-methyl-4,5,6,7,12,13-hexahydrothieno[3,2-e][3]benzazeci n-12-one", AUSTRALIAN JOURNAL OF CHEMISTRY: AN INTERNATIONAL JOURNAL FOR CHEMICAL SCIENCE, C S I R O PUBLISHING, AU, (19880101), vol. 41, no. 1, doi:10.1071/CH9880111, ISSN 0004-9425, pages 111 - 126, XP009179859 [X] 1-4,7 * page 112 - page 113; compounds 5, 11 * DOI: http://dx.doi.org/10.1071/CH9880111 | [X] - K T Potts ET AL, "Synthesis of y-Carbolines", Chemical Communications, (19660101), pages 857 - 858, URL: http://pubs.rsc.org/en/content/articlepdf/1966/c1/c19660000857, (20150107), XP055160215 [X] 1-4,7 * 2,3-benzo; page 858; compound III * | [X] - KNOLKER H-J ET AL, "Transition metal complexes in organic synthesis. Part 62:<1> Total synthesis of (+/-)-demethoxycarbonyldihydrogambirtannine and norketoyobyrine by an iron-mediated [2+2+1] cycloaddition", TETRAHEDRON LETTERS, PERGAMON, GB, (20000624), vol. 41, no. 26, doi:10.1016/S0040-4039(00)00766-8, ISSN 0040-4039, pages 5035 - 5038, XP004222004 [X] 1-4,7 * page 5035; compounds 1a, 1b * DOI: http://dx.doi.org/10.1016/S0040-4039(00)00766-8 | [X] - DIKER K ET AL, "Trapping of Iminiums by the Indole Nucleus during Catalytic Hydrogenation of Nitriles: a Rapid Synthesis of Tetrahydro-beta-carbolines", TETRAHEDRON LETTERS, PERGAMON, GB, (19950403), vol. 36, no. 14, doi:10.1016/0040-4039(95)00293-L, ISSN 0040-4039, pages 2497 - 2500, XP004028321 [X] 1-4,7 * page 2498 - page 2499; compounds 6-7, 13 * DOI: http://dx.doi.org/10.1016/0040-4039(95)00293-L | [X] - JAMES SHORT ET AL, "Notes- New Synthesis of 18-Hydroxy-17-methoxy-15,16,17,18,19,20-hexadehydroyohimbane Hydrochloride.", THE JOURNAL OF ORGANIC CHEMISTRY, (19610701), vol. 26, no. 7, doi:10.1021/jo01351a621, ISSN 0022-3263, pages 2560 - 2561, XP055160238 [X] 1-4,7 * page 2560; compound IVb * DOI: http://dx.doi.org/10.1021/jo01351a621 | [X] - OLIVER KOEPLER ET AL, "Synthesis and DNA binding properties of novel benzo[b]isoquino[2,3-h]-naphthyridines", ORGANIC & BIOMOLECULAR CHEMISTRY, (20050101), vol. 3, no. 15, doi:10.1039/b503281d, ISSN 1477-0520, page 2848, XP055160243 [X] 1-3,7 * page 2850; compound 17 * DOI: http://dx.doi.org/10.1039/b503281d | [X] - Uttam Kumar Panit ET AL, "SYNTHETIC ENTRY INTO YOHIMBINOID ALKALOIDS AND NOVEL SYNTHESIS OF ( )-17-METHOXY-HEXAHYDROYOHIMBANE", Tetrahedron, (19870101), pages 4235 - 4239, URL: http://ac.els-cdn.com/S0040402001834669/1-s2.0-S0040402001834669-main.pdf?_tid=f7beea74-9668-11e4-bc6c-00000aab0f6c&acdnat=1420634010_ea59f437d911fdd1f56e2f99dbeb3d77, (20150107), XP055160272 [X] 1-4 * page 4236; compound 11 * | [X] - K. WEISE ET AL, "Aufbau eines Yohimban-ähnlichen heterocyclus Zweistufensynthese von Benzofuro-benzo-chinolizidin", TETRAHEDRON LETTERS, (19710101), vol. 12, no. 17, doi:10.1016/S0040-4039(01)96673-0, ISSN 0040-4039, pages 1231 - 1232, XP055160274 [X] 1-4,7 * page 1232; compound V * DOI: http://dx.doi.org/10.1016/S0040-4039(01)96673-0 | [X] - ROBIN D. CLARK ET AL, "Stereospecific synthesis of the (3a[alpha],11[alpha],12a[alpha])-decahydrobenzo[ a ]pyrrolo[3,2- g ]quinolizine ring system", JOURNAL OF HETEROCYCLIC CHEMISTRY, (19930501), vol. 30, no. 3, doi:10.1002/jhet.5570300338, ISSN 0022-152X, pages 829 - 831, XP055160279 [X] 1-4,7 * page 829; compound 7 * DOI: http://dx.doi.org/10.1002/jhet.5570300338 | [X] - GLENN C. MORRISON ET AL, "1,4,4a,5,6,8,9,14,14a,14b-1)ecahydrobenz[[alpha]]in(iolo[2,3-g]quinolizinones. A system isomeric with yohimbane", JOURNAL OF HETEROCYCLIC CHEMISTRY, (19711201), vol. 8, no. 6, doi:10.1002/jhet.5570080625, ISSN 0022-152X, pages 1025 - 1026, XP055160284 [X] 1-4,7 * page 1025; compound 2 * DOI: http://dx.doi.org/10.1002/jhet.5570080625 | [X] - S Jeganathan ET AL, "Studies on Heterocyclic Compounds; I. Synthesis of Thiophene Derivatives of Protoberberine Alkaloids", Synthesis, (19790301), pages 195 - 196, URL: https://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-1979-28614.pdf, (20150107), XP055160290 [X] 1-4,7 * page 195; compound 6a * DOI: http://dx.doi.org/10.1055/s-1979-28614 | [X] - GEORGE R. LENZ, "The synthesis of 8-oxoberbines containing a heterocyclic D-ring by enamide photocyclizations", JOURNAL OF HETEROCYCLIC CHEMISTRY, (19790401), vol. 16, no. 3, doi:10.1002/jhet.5570160304, ISSN 0022-152X, pages 433 - 437, XP055160294 [X] 1-4,7 * page 433 - page 434; compounds 4, 7 * DOI: http://dx.doi.org/10.1002/jhet.5570160304 | [X] - V. BOEKELHEIDE ET AL, "The Synthesis of 1,2-Benzo-7,8-(2',3'-indolo)-tetrahydroquinolizine 1", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (19521001), vol. 74, no. 19, doi:10.1021/ja01139a054, ISSN 0002-7863, pages 4920 - 4923, XP055160298 [X] 1-4,7 * page 4920; compound II * DOI: http://dx.doi.org/10.1021/ja01139a054 | [X] - Chihiro Ito, "Chemopreventive Activity of Isoquinoline Alkaloids from Corydalis Plants", Planta Medica, (20010101), pages 473 - 475, URL: https://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2001-15815.pdf, (20150107), XP055160350 [X] 1-4,7 * page 473; figure 1; compounds 3-5 * DOI: http://dx.doi.org/10.1055/s-2001-15815 | [X] - Y-.R. Wu, "Two New Quaternary Alkaloids and Anti-Hepatitis B Virus Active Constituents from Corydalis saxicola", Planta Medica, doi:10.1055/s-2007-98154, (20070101), pages 787 - 791, URL: https://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-981549.pdf, (20150107), XP055160353 [X] 1-4,7 * page 788; compound 5 * DOI: http://dx.doi.org/10.1055/s-2007-981549 | [X] - Thomas Nógrádi, "Untersuchungen über Rauwolfia-Alkaloid-Modelle II 2-Substituierte Indole, Tetrahydrocarbolin- und Hexadehydro-yohimban-Derivate", Monatshefte für Chemie, (19570101), pages 1087 - 1094, URL: http://download.springer.com/static/pdf/356/art%3A10.1007%2FBF00906089.pdf?auth66=1420711766_81fc88890625b641de8221ea9d379426&ext=.pdf, (20150108), XP055160529 [X] 1-4,7 * page 1089; compound XIII * | [X] - SCHAPER K-J, "Free-wilson-type analysis of non-additive substituent effects on THPB", QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, VCH PUBLISHERS, DEERFIELD BEACH, FL, US, (19990101), vol. 18, no. 4, ISSN 0931-8771, pages 354 - 360, XP008123720 [X] 1-4,7 * page 356; compound 9 * | [X] - JEGANATHAN ET AL, "STUDIES ON HETEROCYCLIC COMPOUNDS VI: Synthesis of Thiophene Isosters of Protoberberine Alkaloids", PHOSPHORUS AND SULFUR AND THE RELATED ELEMENTS, GORDON AND BREACH - HARWOOD ACADEMIC, CH, (19810301), vol. 11, doi:0.1080/03086648108077411, ISSN 0308-664X, pages 125 - 137, XP009181842 [X] 1-4,7 * page 127; compounds 12-13 * * page 129 - page 130; compounds 19, 25 * DOI: http://dx.doi.org/0.1080/03086648108077411 | International search | [X]EP0524004 (SYNTEX INC [US]); | [X]WO2008014661 (SHANGHAI INST MATERIA MEDICA [CN], et al); | [X] - SWAN, G.A., "The Constitution of Yohimbine and Related Alkaloids. Part IV. A synthesis of Yohimbone.", JOURNAL OF THE CHEMICAL SOCIETY, (1950), pages 1534 - 1539, XP009003676 DOI: http://dx.doi.org/10.1039/jr9580002038 | [X] - BREMNER, J.B. ET AL., "Derivatives of the Benzo[5,6]cyclohepta[1,2,3-cd]thieno[3,2-c]pyridine System. X-Ray Crystal Structure of 8,9-Dimethoxy-1,2,3,6,11,11 a-hexahydrobenzo[5,6] cyclohepta[1,2,3-cd]thieno[3,2-c] pyridine-l-carbonitrile.", AUSTRALIAN JOURNAL OF CHEMISTRY, (1988), vol. 41, no. 4, pages 575 - 583, XP008174585 DOI: http://dx.doi.org/10.1071/CH9880575 | Examination | WO9422858 | WO9736902 | WO2007006212 | - S C Pakrashi ET AL, "NOVEL BENZOPYRIDOUUINOLIZINE BASES FROM ALANGIUM LAMARCKII THW", Tetrahedron Letters, (19800101), pages 2667 - 2670, URL: http://www.sciencedirect.com/science/article/pii/S0040403900928351/pdf?md5=995dcebc4d3be215a3eace11e95128b7&pid=1-s2.0-S0040403900928351-main.pdf, (20170510), XP055371208 | - JAHANGIR MICHAEL A. BROOK ET AL, "8 H -Isoquino[2,1- b ][2,7]naphthyridin-8-ones: synthesis of the Alangium alkaloids, alangimaridine and alangimarine", CANADIAN JOURNAL OF CHEMISTRY, CA, (19871001), vol. 65, no. 10, doi:10.1139/v87-394, ISSN 0008-4042, pages 2362 - 2368, XP055371242 DOI: http://dx.doi.org/10.1139/v87-394 | - Robert C. Elderfield ET AL, "Alstonia Alkaloids. IX. Synthesis of Alstonilinol and Analogs by Reductive Ring Closure 1", The Journal of Organic Chemistry, (19580701), vol. 23, no. 7, doi:10.1021/jo01101a003, ISSN 0022-3263, pages 949 - 953, XP055371278 DOI: http://dx.doi.org/10.1021/jo01101a003 | - A. I. MEYERS ET AL, "A novel entry into indole alkaloids", THE JOURNAL OF ORGANIC CHEMISTRY, (19820501), vol. 47, no. 11, doi:10.1021/jo00132a063, ISSN 0022-3263, pages 2229 - 2231, XP055371292 DOI: http://dx.doi.org/10.1021/jo00132a063 | - A. Yu Potapov ET AL, "SYNTHESIS OF THE NOVEL HETEROCYCLIC SYSTEM 8,13,13b,14-TETRAHYDROINDOLO- [2,3-a]PYRIMIDO[5,4-g]QUINOLIZIN-5(7H)-ONE", Chemistry of Heterocyclic Compounds, (20120111), pages 1304 - 1305, URL: http://rd.springer.com/content/pdf/10.1007/s10593-012-0908-3.pdf, (20170510), XP055371296 | - AUDIA J E ET AL, "Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B contractile receptor in the rat stomach fundus", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, (19960101), vol. 39, doi:10.1021/JM960062T, ISSN 0022-2623, pages 2773 - 2780, XP002167539 DOI: http://dx.doi.org/10.1021/jm960062t | by applicant | CN1900076 | WO2008014661 | - JIN G Z., TIPS, (2002), pages 23 - 24 | - RICHARD J. SPANGLER; BRIAN G BECKMANN; JONG HO KIM, J ORG CHEM, (1977), vol. 42, pages 2989 - 2996 | - AND MARK CUSHMAN; FREDERICK W. DEKOW, J. ORG CHEM, (1979), vol. 44, pages 407 - 409 | CN20031051464 |